Mar 20, 2025 4:01 pm EDT Skye Bioscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Nov 18, 2024 7:00 am EST Skye Bioscience to Participate in Upcoming December Healthcare Investment Conferences
Nov 14, 2024 7:00 am EST Skye Bioscience Surpasses 50% Patient Enrollment in Phase 2 Obesity Study of Differentiated CB1 Inhibitor